SCHEMBL7991916

SCHEMBL7991916

CCC1C=CC(F)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13369539 0.82
SCHEMBL17355065 0.79
SCHEMBL14724918 0.77
SCHEMBL10080252 0.77
SCHEMBL18725034 0.77
SCHEMBL12320547 0.77
SCHEMBL14197572 0.77
SCHEMBL20825081 0.77
SCHEMBL21170313 0.77
SCHEMBL12087601 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024089049-A1 MODULATORS OF SORTILIN ACTIVITY INSUSENSE ApS (DK) 2024-05-02 WO disclosed
EP-3915989-B1 JAK INHIBITOR AND PREPARATION METHOD THEREFOR FELICAMED BIOTECHNOLOGY CO LTD (CN) 2023-06-28 EP disclosed
CN-116057045-A Fibroblast growth factor receptor kinase inhibitors 金耐特生物制药公司 2023-05-02 CN disclosed
WO-2015152254-A1 FIVE-MEMBERED RING HETEROARYL DERIVATIVE 大日本住友製薬株式会社 2015-10-08 WO disclosed
WO-2011103686-A1 CEPHALOSPORIN DERIVATIVES USEFUL AS β-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF VISWANATHA , SUNDARAMMA (CA) 2011-09-01 WO disclosed
WO-2009133522-A1 PIPERIDINE AND PYRROLIDINE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2009-11-05 WO disclosed
EP-2062959-A2 Novel red electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-05-27 EP disclosed
EP-1551812-B1 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2009-03-04 EP disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed
EP-1218361-B1 OXA- AND THIAZOLE DERIVATIVES USEFUL AS ANTIDIABETIC AND ANTIOBESITY AGENTS BRISTOL MYERS SQUIBB CO (US) 2009-01-07 EP disclosed
US-7345040-B2 Reverse-turn mimetics and compositions and methods relating thereto MYRIAD GENETICS, INC. (US) 2008-03-18 US disclosed